Clinical Trial Update: Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether concurrent use of statins and proton pump inhibitors alters clopidogrel's antiplatelet effects in coronary artery disease. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Omeprazole (Omeprazole)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED